Benjamin Tomlinson
Clinical trials sponsored by Benjamin Tomlinson, explained in plain language.
-
New Low-Dose combo after transplant aims to stop leukemia relapse
Disease control Recruiting nowThis study tests whether a low-dose, weekly chemotherapy combination (decitabine and venetoclax) given after a stem cell transplant can prevent relapse in people with high-risk acute myeloid leukemia or myelodysplastic syndromes. About 20 participants will receive the treatment f…
Phase: PHASE1, PHASE2 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug combo aims to outsmart resistance in bone marrow cancer
Disease control Recruiting nowThis early-phase study tests a new way of giving two approved drugs (5-azacitidine and decitabine) to people with myelodysplastic syndromes (MDS) or related bone marrow disorders. The goal is to see if alternating low doses can overcome drug resistance and improve blood cell prod…
Phase: EARLY_PHASE1 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated May 20, 2026 11:57 UTC